在人类疾病中剖析转录因子EB (TFEB) 的多面性功能:从分子机制到药理学调制
Lijuan Zhang1, Zhijia Li2, Lan Zhang2
1Department of Pharmacy, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China; Personalized Drug Therapy Key Laboratory of Sichuan Province, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China.
Biochemical pharmacology
|July 23, 2023
概括
转录因子EB (TFEB) 通过控制 lysosomal 功能和自来调节细胞平衡. 调节TFEB活性为许多疾病提供治疗潜力,包括癌症和神经退行.
科学领域:
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 转录因子EB (TFEB) 是细胞平衡的关键调节者.
- 在细胞应激时,TFEB转移到细胞核,激活用于溶酶体功能,自和脂质代谢的基因.
- TFEB的失调与癌症,神经退行症和代谢障碍等各种疾病有关.
研究的目的:
- 审查TFEB监管机制中最近的发现.
- 探索TFEB失调对人类疾病的影响.
- 总结当前的TFEB调制器,并确定未来的研究方向.
主要方法:
- 对TFEB法规的文献综述.
- 分析TFEB在各种疾病病理中的作用.
- 已知TFEB激动剂和抑制剂的汇编.
主要成果:
- 突出了TFEB在维持细胞平衡中的关键作用.
- 建立了TFEB失调与多种人类疾病之间的联系.
- 介绍了TFEB调制剂 (激动剂和抑制剂) 的全面概述.
结论:
- TFEB是细胞健康和疾病的关键因素.
- 调节TFEB活动提供了重要的治疗机会.
- 对TFEB调节和向治疗的进一步研究有必要进行临床转化.
更多相关视频
相关概念视频
Transcription Factors
76.1K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
76.1K
General Transcription Factors
5.4K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.4K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
Eukaryotic Transcription Inhibitors
9.9K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.9K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K


